Literature DB >> 30281091

Cis D4Z4 repeat duplications associated with facioscapulohumeral muscular dystrophy type 2.

Richard J L F Lemmers1, Patrick J van der Vliet1, Jeroen P Vreijling2, Don Henderson3, Nienke van der Stoep2, Nicol Voermans4, Baziel van Engelen4, Frank Baas2, Sabrina Sacconi5, Rabi Tawil3, Silvère M van der Maarel1.   

Abstract

Facioscapulohumeral muscular dystrophy, known in genetic forms FSHD1 and FSHD2, is associated with D4Z4 repeat array chromatin relaxation and somatic derepression of DUX4 located in D4Z4. A complete copy of DUX4 is present on 4qA chromosomes, but not on the D4Z4-like repeats of chromosomes 4qB or 10. Normally, the D4Z4 repeat varies between 8 and 100 units, while in FSHD1 it is only 1-10 units. In the rare genetic form FSHD2, a combination of a 4qA allele with a D4Z4 repeat size of 8-20 units and heterozygous pathogenic variants in the chromatin modifier SMCHD1 causes DUX4 derepression and disease. In this study, we identified 11/79 (14%) FSHD2 patients with unusually large 4qA alleles of 21-70 D4Z4 units. By a combination of Southern blotting and molecular combing, we show that 8/11 (73%) of these unusually large 4qA alleles represent duplication alleles in which the long D4Z4 repeat arrays are followed by a small FSHD-sized D4Z4 repeat array duplication. We also show that these duplication alleles are associated with DUX4 expression. This duplication allele frequency is significantly higher than in controls (2.9%), FSHD1 patients (1.4%) and in FSHD2 patients with typical 4qA alleles of 8-20 D4Z4 units (1.5%). Segregation analysis shows that, similar to typical 8-20 units FSHD2 alleles, duplication alleles only cause FSHD in combination with a pathogenic variant in SMCHD1. We conclude that cis duplications of D4Z4 repeats explain DUX4 expression and disease presentation in FSHD2 families with unusual long D4Z4 repeats on 4qA chromosomes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30281091      PMCID: PMC6168970          DOI: 10.1093/hmg/ddy236

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  40 in total

1.  Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin.

Authors:  Michel van Geel; Morag C Dickson; Amy F Beck; Daniel J Bolland; Rune R Frants; Silvère M van der Maarel; Pieter J de Jong; Jane E Hewitt
Journal:  Genomics       Date:  2002-02       Impact factor: 5.736

2.  Hybridization analysis of D4Z4 repeat arrays linked to FSHD.

Authors:  Melanie Ehrlich; Kesmic Jackson; Koji Tsumagari; Pilar Camaño; Richard J F L Lemmers
Journal:  Chromosoma       Date:  2006-11-28       Impact factor: 4.316

3.  Molecular combing reveals complex 4q35 rearrangements in Facioscapulohumeral dystrophy.

Authors:  Karine Nguyen; Francesca Puppo; Stéphane Roche; Marie-Cécile Gaillard; Charlène Chaix; Arnaud Lagarde; Marjorie Pierret; Catherine Vovan; Sylviane Olschwang; Emmanuelle Salort-Campana; Shahram Attarian; Marc Bartoli; Rafaëlle Bernard; Frédérique Magdinier; Nicolas Levy
Journal:  Hum Mutat       Date:  2017-08-06       Impact factor: 4.878

4.  Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2.

Authors:  Richard J L F Lemmers; Jelle J Goeman; Patrick J van der Vliet; Merlijn P van Nieuwenhuizen; Judit Balog; Marianne Vos-Versteeg; Pilar Camano; Maria Antonia Ramos Arroyo; Ivonne Jerico; Mark T Rogers; Daniel G Miller; Meena Upadhyaya; Jan J G M Verschuuren; Adolfo Lopez de Munain Arregui; Baziel G M van Engelen; George W Padberg; Sabrina Sacconi; Rabi Tawil; Stephen J Tapscott; Bert Bakker; Silvère M van der Maarel
Journal:  Hum Mol Genet       Date:  2014-09-25       Impact factor: 6.150

5.  Hemizygosity for SMCHD1 in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion Syndrome.

Authors:  Richard J L F Lemmers; Marlinde L van den Boogaard; Patrick J van der Vliet; Colleen M Donlin-Smith; Sharon P Nations; Claudia A L Ruivenkamp; Patricia Heard; Bert Bakker; Stephen Tapscott; Jannine D Cody; Rabi Tawil; Silvère M van der Maarel
Journal:  Hum Mutat       Date:  2015-05-20       Impact factor: 4.878

6.  DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy.

Authors:  Linda N Geng; Zizhen Yao; Lauren Snider; Abraham P Fong; Jennifer N Cech; Janet M Young; Silvere M van der Maarel; Walter L Ruzzo; Robert C Gentleman; Rabi Tawil; Stephen J Tapscott
Journal:  Dev Cell       Date:  2011-12-29       Impact factor: 12.270

7.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy.

Authors:  Richard J L F Lemmers; Marielle Wohlgemuth; Kristiaan J van der Gaag; Patrick J van der Vliet; Corrie M M van Teijlingen; Peter de Knijff; George W Padberg; Rune R Frants; Silvere M van der Maarel
Journal:  Am J Hum Genet       Date:  2007-09-07       Impact factor: 11.025

9.  A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1.

Authors:  Mariëlle Wohlgemuth; Richard J Lemmers; Marianne Jonker; Elly van der Kooi; Corinne G Horlings; Baziel G van Engelen; Silvere M van der Maarel; George W Padberg; Nicol C Voermans
Journal:  Neurology       Date:  2018-07-11       Impact factor: 9.910

10.  Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling.

Authors:  Isabella Scionti; Greta Fabbri; Chiara Fiorillo; Giulia Ricci; Francesca Greco; Roberto D'Amico; Alberto Termanini; Liliana Vercelli; Giuliano Tomelleri; Michelangelo Cao; Lucio Santoro; Antonio Percesepe; Rossella Tupler
Journal:  J Med Genet       Date:  2012-01-03       Impact factor: 6.318

View more
  10 in total

1.  FSHD1 and FSHD2 form a disease continuum.

Authors:  Sabrina Sacconi; Audrey Briand-Suleau; Marilyn Gros; Christian Baudoin; Richard J L F Lemmers; Sophie Rondeau; Nadira Lagha; Pilvi Nigumann; Chiara Cambieri; Angela Puma; Françoise Chapon; Tanya Stojkovic; Christophe Vial; Françoise Bouhour; Michelangelo Cao; Elena Pegoraro; Philippe Petiot; Anthony Behin; Bras Marc; Bruno Eymard; Andoni Echaniz-Laguna; Pascal Laforet; Leonardo Salviati; Marc Jeanpierre; Gaël Cristofari; Silvère M van der Maarel
Journal:  Neurology       Date:  2019-04-12       Impact factor: 9.910

2.  SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain.

Authors:  Richard J L F Lemmers; Nienke van der Stoep; Patrick J van der Vliet; Steven A Moore; David San Leon Granado; Katherine Johnson; Ana Topf; Volker Straub; Teresinha Evangelista; Tahseen Mozaffar; Virginia Kimonis; Natalie D Shaw; Rita Selvatici; Alessandra Ferlini; Nicol Voermans; Baziel van Engelen; Sabrina Sacconi; Rabi Tawil; Meindert Lamers; Silvère M van der Maarel
Journal:  J Med Genet       Date:  2019-06-26       Impact factor: 6.318

3.  High-resolution breakpoint junction mapping of proximally extended D4Z4 deletions in FSHD1 reveals evidence for a founder effect.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; David San Leon Granado; Nienke van der Stoep; Henk Buermans; Robin van Schendel; Joost Schimmel; Marianne de Visser; Rudy van Coster; Marc Jeanpierre; Pascal Laforet; Meena Upadhyaya; Baziel van Engelen; Sabrina Sacconi; Rabi Tawil; Nicol C Voermans; Mark Rogers; Silvère M van der Maarel
Journal:  Hum Mol Genet       Date:  2022-03-03       Impact factor: 5.121

4.  Epigenetic patterns in a complete human genome.

Authors:  Ariel Gershman; Michael E G Sauria; Xavi Guitart; Mitchell R Vollger; Paul W Hook; Savannah J Hoyt; Miten Jain; Alaina Shumate; Roham Razaghi; Sergey Koren; Nicolas Altemose; Gina V Caldas; Glennis A Logsdon; Arang Rhie; Evan E Eichler; Michael C Schatz; Rachel J O'Neill; Adam M Phillippy; Karen H Miga; Winston Timp
Journal:  Science       Date:  2022-04-01       Impact factor: 63.714

5.  CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis.

Authors:  Autumn Rieken; Aaron D Bossler; Katherine D Mathews; Steven A Moore
Journal:  Neurology       Date:  2020-12-21       Impact factor: 9.910

Review 6.  Facioscapulohumeral muscular dystrophy-Reproductive counseling, pregnancy, and delivery in a complex multigenetic disease.

Authors:  Sanne C C Vincenten; Nienke Van Der Stoep; Aimée D C Paulussen; Karlien Mul; Umesh A Badrising; Marjolein Kriek; Olivier W H Van Der Heijden; Baziel G M Van Engelen; Nicol C Voermans; Christine E M De Die-Smulders; Saskia Lassche
Journal:  Clin Genet       Date:  2021-08-01       Impact factor: 4.296

7.  Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations.

Authors:  N C Voermans; R C van der Bilt; J IJspeert; J Y Hogrel; M Jeanpierre; A Behin; P Laforet; T Stojkovic; B G van Engelen; G W Padberg; S Sacconi; R J L F Lemmers; S M van der Maarel; B Eymard; G Bassez
Journal:  J Neurol       Date:  2019-08-31       Impact factor: 4.849

8.  Diagnostic capabilities of nanopore long-read sequencing in muscular dystrophy.

Authors:  Christine C Bruels; Hannah R Littel; Audrey L Daugherty; Seth Stafki; Elicia A Estrella; Emily S McGaughy; Don Truong; Jonathan P Badalamenti; Lynn Pais; Vijay S Ganesh; Anne O'Donnell-Luria; Heather J Stalker; Yang Wang; Christin Collins; Andrea Behlmann; Richard J L F Lemmers; Silvère M van der Maarel; Regina Laine; Partha S Ghosh; Basil T Darras; Carla D Zingariello; Christina A Pacak; Louis M Kunkel; Peter B Kang
Journal:  Ann Clin Transl Neurol       Date:  2022-06-23       Impact factor: 5.430

Review 9.  Update on the Molecular Aspects and Methods Underlying the Complex Architecture of FSHD.

Authors:  Valerio Caputo; Domenica Megalizzi; Carlo Fabrizio; Andrea Termine; Luca Colantoni; Carlo Caltagirone; Emiliano Giardina; Raffaella Cascella; Claudia Strafella
Journal:  Cells       Date:  2022-08-29       Impact factor: 7.666

Review 10.  Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy.

Authors:  Anna Greco; Remko Goossens; Baziel van Engelen; Silvère M van der Maarel
Journal:  Clin Genet       Date:  2020-03-04       Impact factor: 4.438

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.